| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 9 2864-2871, Copyright © 1992 by American Association of Immunologists
ARTICLES |
A Geluk, KE Van Meijgaarden, AA Janson, JW Drijfhout, RH Meloen, RR De Vries and TH Ottenhoff
Department of Immunohematology and Blood Bank, University Hospital, Leiden, The Netherlands.
We have previously shown that p3-13 (KTIAY-DEEARR) of the 65-kDa heat shock protein (hsp65) of Mycobacterium tuberculosis and Mycobacterium leprae is selected as an important T cell epitope in HLA-DR17+ individuals, by selectively binding to (a pocket in) DR17 molecules, the major subset of the DR3 specificity. We have now further studied the interaction between p3-13, HLA-DR17 and four different TCR (V beta 5.1, V beta 1, and V beta 4) by using T cell stimulation assays, direct peptide-DR binding assays, and a large panel (n = 240) of single amino acid substitution analogs of p3-13. We find that residues 5(I) and 8(D) of p3-13 are important DR17 binding residues, whereas the residues that interact with the TCR vary slightly for each DR17-restricted clone. By using N- and C-terminal truncated derivatives of p2-20 we defined the minimal peptide length for both HLA-DR17 binding and T cell activation: the minimal peptide that bound to DR17 was seven amino acids long whereas the minimal peptide that activated T cell proliferation was eight amino acids in length. Furthermore, two new DR17-restricted epitopes were identified on hsp70 and hsp18 of M. leprae. Alignment of the critical DR17-binding residues 5(I) and 8(D) of p3-13 with these two novel epitopes and two other DR17-binding peptides revealed the presence of highly conserved amino acids at positions n and n + 3 with I, L, and V at position n and D and E at position n + 3. D and E are particularly likely to interact with the DR17-specific, positively charged pocket that we have defined earlier. Based on these results, a set of single amino acid substituted analogs that failed to activate these T cell clones but still bound specifically to DR17 was defined and tested for their ability to inhibit T cell activation by p3-13 or other DR17-restricted epitopes. Those peptides were able to inhibit the response to p3-13 as well as other DR17-restricted mycobacterial epitopes in an allele-specific manner, and are anticipated to be of potential use for immunotherapeutic and vaccine design strategies.
This article has been cited by other articles:
|
|
 |
|
  S. A. Joosten, K. E. van Meijgaarden, N. D. L. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. M. Ottenhoff Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4 PNAS, May 8, 2007; 104(19): 8029 - 8034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Doytchinova and D. R. Flower In Silico Identification of Supertypes for Class II MHCs J. Immunol., June 1, 2005; 174(11): 7085 - 7095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Ressing, D. van Leeuwen, F. A. W. Verreck, R. Gomez, B. Heemskerk, M. Toebes, M. M. Mullen, T. S. Jardetzky, R. Longnecker, M. W. Schilham, et al. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition PNAS, September 30, 2003; 100(20): 11583 - 11588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Doebele, A. Pashine, W. Liu, D. M. Zaller, M. Belmares, R. Busch, and E. D. Mellins Point Mutations in or Near the Antigen-Binding Groove of HLA-DR3 Implicate Class II-Associated Invariant Chain Peptide Affinity as a Constraint on MHC Class II Polymorphism J. Immunol., May 1, 2003; 170(9): 4683 - 4692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wienhold, G. Malcherek, C. Jung, S. Stevanovic, G. Jung, H. Schild, and A. Melms An example of immunodominance: engagement of synonymous TCR by invariant CDR3{beta} Int. Immunol., June 1, 2000; 12(6): 747 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rea, C. van Kooten, K. E. van Meijgaarden, T. H. M. Ottenhoff, C. J. M. Melief, and R. Offringa Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10 Blood, May 15, 2000; 95(10): 3162 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. van Ham, M. van Lith, B. Lillemeier, E. Tjin, U. Gruneberg, D. Rahman, L. Pastoors, K. van Meijgaarden, C. Roucard, J. Trowsdale, et al. Modulation of the Major Histocompatibility Complex Class II-associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (HLA)-DO J. Exp. Med., March 27, 2000; 191(7): 1127 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rea, F. H. E. Schagen, R. C. Hoeben, M. Mehtali, M. J. E. Havenga, R. E. M. Toes, C. J. M. Melief, and R. Offringa Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset J. Virol., December 1, 1999; 73(12): 10245 - 10253. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Esin, G. Batoni, G. Saruhan-Direskeneli, R. A. Harris, J. Grunewald, M. Pardini, S. B. Svenson, M. Campa, and H. Wigzell In Vitro Expansion of T-Cell-Receptor Valpha 2.3+ CD4+ T Lymphocytes in HLA-DR17(3), DQ2+ Individuals upon Stimulation with Mycobacterium tuberculosis Infect. Immun., August 1, 1999; 67(8): 3800 - 3809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gregori, S. Trembleau, G. Penna, F. Gallazzi, J. Hammer, G. K. Papadopoulos, and L. Adorini A Peptide Binding Motif for I-Eg7, the MHC Class II Molecule That Protects E{alpha}-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes J. Immunol., June 1, 1999; 162(11): 6630 - 6640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. de Koster, C. J. Vermeulen, H. S. Hiemstra, R. Amons, J. W. Drijfhout, and F. Koning Definition of agonists and design of antagonists for alloreactive T cell clones using synthetic peptide libraries Int. Immunol., April 1, 1999; 11(4): 585 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagvekar, L. Corlett, L. W. Jacobson, H. Matsuo, R. Chalkley, P. C. Driscoll, S. Deshpande, E. G. Spack, and N. Willcox Scanning a DRB3*0101 (DR52a)-Restricted Epitope Cross-Presented by DR3: Overlapping Natural and Artificial Determinants in the Human Acetylcholine Receptor J. Immunol., April 1, 1999; 162(7): 4079 - 4087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Hiemstra, P. A. van Veelen, N. C. Schloot, A. Geluk, K. E. van Meijgaarden, S. J. M. Willemen, J. A. M. Leunissen, W. E. Benckhuijsen, R. Amons, R. R. P. de Vries, et al. Definition of Natural T Cell Antigens with Mimicry Epitopes Obtained from Dedicated Synthetic Peptide Libraries J. Immunol., October 15, 1998; 161(8): 4078 - 4082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Godkin, M. P. Davenport, A. Willis, D. P. Jewell, and A. V. S. Hill Use of Complete Eluted Peptide Sequence Data from HLA-DR and -DQ Molecules to Predict T Cell Epitopes, and the Influence of the Nonbinding Terminal Regions of Ligands in Epitope Selection J. Immunol., July 15, 1998; 161(2): 850 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kropshofer, A. B. Vogt, L. J. Stern, and Gün. J. Hämmerling Self-Release of CLIP in Peptide Loading of HLA-DR Molecules Science, November 24, 1995; 270(5240): 1357 - 1359. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
